Legendary Trader: “Buy These Three Stocks Before this September Event”

Luke Lango believes an event scheduled for mid-September is set to trigger a massive market shock, potentially defining the winners and losers for the rest of the year.  

Wed, September 11 at 8:00PM ET
 
 
 
 
Register Here
Healthcare Stocks Icon

Healthcare Stocks

Healthcare encompasses a wide range of organized services to prevent, treat, and diagnose medical needs and mental illnesses. The $336 billion market is expected to grow at a compound annual growth rate of 8% until 2030, demonstrating the necessity of adequate healthcare. Healthcare companies, ranging from retailer CVS to insurance giant UnitedHealth, provide these services to a massive customer base.

The words "recession proof" written on a pink sticky note. bulletproof stocks

7 Recession-Resistant Stocks to Hold Onto for Dear Life in 2024

These seven recession-resistant stocks offer stability and potential growth even in challenging economic conditions.

Interest rate and dividend concept. Businessman with percentage symbol and up arrow, Interest rates continue to increase, return on stocks and mutual funds, long term investment for retirement. Dividend stocks

7 Dependable Dividend Stocks for Long-Term Income

Explore the best dividend stocks for long-term income excelling in the healthcare, retail, tobacco and home improvement markets.

medicine research, pharmaceutical background, LJPC stock

3 Pharmaceutical Stocks That Can Surge Higher Even if The Markets Correct

These are the pharmaceutical stocks to buy as they represent undervalued companies with a deep clinical pipeline that will support growth.

Other industries you might be interested in

Icon depicting a DNA strand

Biotech

Marijuana leaf

Cannabis

Icon depicting pills

Psychedelics

Recent Healthcare Stocks Articles

The 7 Best Meme Stocks to Buy in January 2024

By Faisal Humayun, InvestorPlace Contributor
These are the best meme stocks to buy as they represent companies with a positive business outlook and high social media interest.

Financial Frontrunners: 3 Stocks Where the Big Money Is Moving in 2024

By Yiannis Zourmpanos, InvestorPlace Contributor
The 2024 investment trends are slowly making themselves known. Make sure you follow our guide to stay ahead of the curb.

3 Megatrend Stocks that Will Revolutionize Your Portfolio

By Matthew Farley, InvestorPlace Contributor
Consider these powerhouse stocks for likely significant capital appreciation, growth, and rewards for your portfolio.

3 Stocks to Buy in the Booming Field of Gene Editing

By Chris Markoch, InvestorPlace Contributor
As the promise of gene editing moves closer to being a reality, these gene editing stocks have the opportunity for long-term gains.

Dividend Dynasty: 7 High-Yield Stocks for Long-Term Wealth Accumulation

By Yiannis Zourmpanos, InvestorPlace Contributor
For inventors looking for a financial compass to navigate the sea of investments, here is the realm of the "Dividend Dynasty."

3 Penny Stocks to Buy to Unlock 2,500% Upside Potential

By Omor Ibne Ehsan
These penny stocks have triple-digit upside as 2024 brings easing monetary policy and economic normalization.

3 Once-in-a-Lifetime Stocks on the Verge of an Unprecedented Surge

By Yiannis Zourmpanos, InvestorPlace Contributor
Dive into the strategies of three stocks primed for a surge, uncovering secrets of their extraordinary growth.

Budding Prospects: 3 Cannabis Stocks Primed for Growth

By Rick Orford, InvestorPlace Contributor
Cannabis stocks are seeing growth due to increasing acceptance and legalization. Ride the industry's expansion with these three stocks.

Pfizer’s 2024 Outlook: Is PFE Stock Poised for a Major Rebound?

By Chris MacDonald, InvestorPlace Contributor
Pfizer is certainly a company that will need to continue to battle headwinds moving forward, but is PFE stock worth a buy?

Why Is Clearmind Medicine (CMND) Stock Down 24% Today?

By William White, InvestorPlace Writer
Clearmind Medicine stock is falling on Thursday after shares of CMND underwent a major rally yesterday on a meeting with regulators.

The 3 Best Dividend Stocks to Buy in January 2024

By Terel Miles, InvestorPlace Contributor
For income-oriented investors, these are the three best dividend stocks to buy this year for their stability and upside potential.

Why Is Atreca (BCEL) Stock Up 85% Today?

By William White, InvestorPlace Writer
Atreca stock is heading higher on Thursday as investors react to news of Baker Bros. Advisors LP increasing its stake in the company.

If You Can Only Buy One Biotech Stock in January, It Better Be One of These 3 Names

By Gabriel Osorio-Mazzilli, InvestorPlace Contributor
Biotech is one of the areas of interest in the market today, adding a biotech stock could be huge play this month.

The 3 Best Blue-Chip Stocks to Buy in January 2024

By Charles Munyi, InvestorPlace Contributor
With a history of consistent shareholder returns, the best blue-chip stocks will reward patient investors in 2024.

New AI System Says These 7 Stocks Will Dominate 2024

By Omor Ibne Ehsan
Carefully applying human judgment and an AI's analysis can help identify the true opportunities and dangers in this market.

The 3 Best Cannabis Stocks to Buy in January 2024

By Ian Cooper, InvestorPlace Contributor
With the 2024 U.S. presidential election just months away, some of the best cannabis stocks should benefit.

Gilead’s Quiet Revolution: Is GILD the Next Big Stock to Soar?

By David Moadel, InvestorPlace Contributor
While Wall Street obsesses over weight-loss drugs, Gilead Sciences is working on life-saving treatments and GILD stock looks ready to rally.

Fuzzy Panda Slams DocGo (DCGO) Stock in New Short Report

By Eddie Pan, InvestorPlace Financial News Writer
DCGO stock is in focus following the publication of a DocGo short report by Fuzzy Panda, alleging fraud and improper billing practices.

Why Is Xeris Biopharma (XERS) Stock Up 12% Today?

By William White, InvestorPlace Writer
Xeris Biopharma stock is rising higher on Wednesday as investors in XERS shares react to a new exclusive worldwide license agreement.
Load More Articles